Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-29T14:52:56.065Z Has data issue: false hasContentIssue false

Effect of priming on adjunctive repetitive transcranial magnetic stimulation in treatment of late-life depression: protocol of a prospective randomized sham-controlled study

Published online by Cambridge University Press:  07 October 2022

Kote L. Vidya
Affiliation:
Department of Geriatric Mental Health, King George’s Medical University, Lucknow, India
Shrikant Srivastava
Affiliation:
Department of Geriatric Mental Health, King George’s Medical University, Lucknow, India
Bhupendra Singh
Affiliation:
Department of Geriatric Mental Health, King George’s Medical University, Lucknow, India
Sujita K. Kar*
Affiliation:
Department of Psychiatry, King George’s Medical University, Lucknow, India
*
*Author for correspondence: Sujita K. Kar, MD, Email: drsujita@gmail.com

Abstract

Objective

Priming stimulation, which involves high-frequency repetitive transcranial magnetic stimulation (rTMS) followed by low-frequency, has been shown to enhance neural response and is one of the novel paradigms found beneficial in adult patients with depression and has not been studied in late-life depression (LLD). This study aims to compare the effect of adjunctive priming vis-a-vis no priming rTMS over right dorso-lateral prefrontal cortex (DLPFC), on treatment of LLD.

Methods

This trial is registered in Clinical Trial Registry-India (CTRI) on www.ctri.nic.in. CTRI registration number: CTRI/2020/08/027230. Forty patients of LLD who are symptomatic after an adequate antidepressant trial will be randomized into 2 groups (active priming and sham priming rTMS); each receiving 10 sessions of rTMS over 2 weeks. Patients will remain blind to treatment allocation. Assessments will be done using Hamilton rating scale for depression, Geriatric Depression Scale, Hamilton rating scale for Anxiety, Somatic Symptom Severity Scale 8, Hindi Mental Status Examination, and Clinical Global Impression scale at baseline, week 1, 2, and 4. Side effect checklist will be applied after each session in both groups and at the end of 4 weeks.

Result

Data will be analyzed using statistical software Statistical Package for Social Sciences. Both the groups (active and sham groups) will be compared at the four given timepoints. Also, the baseline characteristics will be compared with the 3 follow-up points for any change.

Conclusion

The findings of the study will give an insight to the possible role of priming to augment the effect of low-frequency rTMS in LLD.

Type
Original Research
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alexopoulos, GS. Mechanisms and treatment of late-life depression. Transl Psychiatry. 2019;9(1):188. doi:10.1038/s41398-019-0514-6.CrossRefGoogle Scholar
Tedeschini, E, Levkovitz, Y, Iovieno, N, Ameral, VE, Nelson, JC, Papakostas, GI. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin Psychiatry. 2011;72(12):16601668. doi:10.4088/JCP.10r06531.CrossRefGoogle Scholar
Álamo, C, López-Muñoz, F, García-García, P, García-Ramos, S. Risk-benefit analysis of antidepressant drug treatment in the elderly: antidepressants in the elderly. Psychogeriatrics. 2014;14(4):261268. doi:10.1111/psyg.12057.CrossRefGoogle Scholar
Lenze, EJ, Sheffrin, M, Driscoll, HC, et al. Incomplete response in late-life depression: getting to remission. Dialogues Clin Neurosci. 2008;10(4):419430. doi:10.31887/DCNS.2008.10.4/jlenze.CrossRefGoogle Scholar
Lenze, EJ, Mulsant, BH, Blumberger, DM, et al. Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial. The Lancet. 2015;386(10011):24042412. doi:10.1016/S0140-6736(15)00308-6.CrossRefGoogle Scholar
Srivastava, S, Kumar, A, Khurana, H, Tiwari, S, Akbar, S. Short-term course and outcome of late-life depression. J Geriatr Ment Health. 2015;2(2):96. doi:10.4103/2348-9995.174275.CrossRefGoogle Scholar
Beekman, ATF, Geerlings, SW, Deeg, DJH, et al. The natural history of late-life depression: a 6-year prospective study in the community. Arch Gen Psychiatry. 2002;59(7):605. doi:10.1001/archpsyc.59.7.605.CrossRefGoogle Scholar
Knochel, C, Alves, G, Friedrichs, B, et al. Treatment-resistant late-life depression: challenges and perspectives. Curr Neuropharmocol. 2015;13(5):577591. doi:10.2174/1570159X1305151013200032.CrossRefGoogle ScholarPubMed
Sabesan, P, Lankappa, S, Khalifa, N, Krishnan, V, Gandhi, R, Palaniyappan, L. Transcranial magnetic stimulation for geriatric depression: promises and pitfalls. World J Psychiatry 2015;5(2):170. doi:10.5498/wjp.v5.i2.170.CrossRefGoogle Scholar
Cappon, D, den Boer, T, Jordan, C, Yu, W, Metzger, E, Pascual-Leone, A. Transcranial magnetic stimulation (TMS) for geriatric depression. Ageing Res Rev. 2022;74:101531. doi:10.1016/j.arr.2021.101531.CrossRefGoogle ScholarPubMed
Kaster, TS, Daskalakis, ZJ, Noda, Y, et al. Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial. Neuropsychopharmacology. 2018;43(11):22312238. doi:10.1038/s41386-018-0121-x.CrossRefGoogle Scholar
Jorge, RE, Moser, DJ, Acion, L, Robinson, RG. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry. 2008;65(3):268276. doi:10.1001/archgenpsychiatry.2007.45.CrossRefGoogle Scholar
Mosimann, UP, Schmitt, W, Greenberg, BD, et al. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Res. 2004;126(2):123133. doi:10.1016/j.psychres.2003.10.006.CrossRefGoogle Scholar
Fitzgerald, PB, Hoy, K, McQueen, S, et al. Priming stimulation enhances the effectiveness of low-frequency right prefrontal cortex transcranial magnetic stimulation in major depression. J Clin Psychopharmacol. 2008;28(1):5258. doi:10.1097/jcp.0b013e3181603f7c.CrossRefGoogle Scholar
Vidya, KL, Rao, PG, Goyal, N. Adjuvant priming repetitive transcranial magnetic stimulation for treatment-resistant obsessive-compulsive disorder: in search of a new paradigm! J ECT. 2022;38(1):e1e8. doi:10.1097/YCT.0000000000000791.CrossRefGoogle Scholar
Rothärmel, M, Quesada, P, Husson, T, et al. The priming effect of repetitive transcranial magnetic stimulation on clinical response to electroconvulsive therapy in treatment-resistant depression: a randomized, double-blind, sham-controlled study. Psychol. Med. 2021;28:112. doi:10.1017/S0033291721003810.Google Scholar
McClintock, SM, Reti, IM, Carpenter, LL, et al. Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression: (consensus statement). J Clin Psychiatry. 2018;79(1):3548. doi:10.4088/JCP.16cs10905.CrossRefGoogle Scholar
Lefaucheur, JP, André-Obadia, N, Antal, A, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clinical Neurophysiol. 2014;125(11):21502206. doi:10.1016/j.clinph.2014.05.021.CrossRefGoogle Scholar
Nongpiur, A, Sinha, VK, Praharaj, SK, Theta-Patterned, GN. Frequency-modulated priming stimulation enhances low-frequency, right prefrontal cortex repetitive transcranial magnetic stimulation (rTMS) in depression: a randomized, sham-controlled study. JNP. 2011;23(3):348357. doi:10.1176/jnp.23.3.jnp348.CrossRefGoogle Scholar
Ray, P, Sinha, VK, Tikka, SK. Adjuvant low-frequency rTMS in treating auditory hallucinations in recent-onset schizophrenia: a randomized controlled study investigating the effect of high-frequency priming stimulation. Ann Gen Psychiatry. 2015;14(1):8. doi:10.1186/s12991-015-0046-2.CrossRefGoogle Scholar
Zhang, JJ, Fong, KNK. Effects of priming intermittent theta burst stimulation on upper limb motor recovery after stroke: study protocol for a proof-of-concept randomised controlled trial. BMJ Open. 2020;10(3):e035348. doi:10.1136/bmjopen-2019-035348.CrossRefGoogle Scholar
Valiengo, L, Maia, A, Cotovio, G, et al. Repetitive transcranial magnetic stimulation for major depressive disorder in older adults: Systematic review and meta-analysis. J Gerontol A. 2021;77:851860. doi:10.1093/gerona/glab235.CrossRefGoogle Scholar
Berlim, MT, Van den Eynde, F, Jeff Daskalakis, Z. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacol. 2013;38(4):543551. doi:10.1038/npp.2012.237.CrossRefGoogle Scholar
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization; 1993.Google Scholar
Alper, K, Schwartz, KA, Kolts, RL, Khan, A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62(4):345354. doi:10.1016/j.biopsych.2006.09.023.CrossRefGoogle Scholar
Kanner, AM. Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: a review of the evidence. Epilepsy & Behavior. 2016;61:282286. doi:10.1016/j.yebeh.2016.03.022.CrossRefGoogle Scholar
Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):5662. doi:10.1136/jnnp.23.1.56.CrossRefGoogle Scholar
Hamilton, M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):5055. doi:10.1111/j.2044-8341.1959.tb00467.x.CrossRefGoogle Scholar
Yesavage, JA, Brink, TL, Rose, TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiat Res. 1982;17(1):3749. doi:10.1016/0022-3956(82)90033-4.CrossRefGoogle Scholar
Ganguli, M, Dube, S, Johnston, JM, Pandav, R, Chandra, V, Dodge, HH. Depressive symptoms, cognitive impairment and functional impairment in a rural elderly population in India: a Hindi version of the geriatric depression scale (GDS-H). Int J Geriatr Psychiatry. 1999;14(10):807820.3.0.CO;2-#>CrossRefGoogle Scholar
Mehra, A, Agarwal, A, Bashar, M, Grover, S. Evaluation of psychometric properties of hindi versions of geriatric depression scale and patient health questionnaire in older adults. Indian J Psychologic Med. 2021;43(4):319324. doi:10.1177/02537176211022159.CrossRefGoogle Scholar
Gierk, B, Kohlmann, S, Kroenke, K, et al. The somatic symptom scale–8 (SSS-8): a brief measure of somatic symptom burden. JAMA Intern Med. 2014;174(3):399. doi:10.1001/jamainternmed.2013.12179.CrossRefGoogle Scholar
Ganguli, M, Ratcliff, G, Chandra, V, et al. A hindi version of the MMSE: The development of a cognitive screening instrument for a largely illiterate rural elderly population in India. Int J Geriat Psychiatry. 1995;10(5):367377. doi:10.1002/gps.930100505.CrossRefGoogle Scholar
Rossi, S, Hallett, M, Rossini, PM, Pascual-Leone, A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):20082039. doi:10.1016/j.clinph.2009.08.016.CrossRefGoogle Scholar
Slotema, CW, Blom, JD, Hoek, HW, Sommer, IEC. Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? a meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry. 2010;71(07):873884. doi:10.4088/JCP.08m04872gre.CrossRefGoogle Scholar
Mandal, MK, Pandey, G, Singh, SK, Asthana, HS. Hand preference in India. Int J Psychol. 1992;27(6):433442. doi:10.1080/00207599208246907.CrossRefGoogle Scholar
Chan, AW, Tetzlaff, JM, Altman, DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200. doi:10.7326/0003-4819-158-3-201302050-00583.CrossRefGoogle Scholar
Pridmore, S, Fernandes Filho, JA, Nahas, Z, Liberatos, C, George, MS. Motor threshold in transcranial magnetic stimulation: a comparison of a neurophysiological method and a visualization of movement method. J ECT. 1998;14(1):2527.CrossRefGoogle Scholar
Herwig, U, Satrapi, P, Schönfeldt-Lecuona, C. Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr. 2003;16(2):9599. doi:10.1023/B:BRAT.0000006333.93597.9d.CrossRefGoogle Scholar
Speer, AM, Kimbrell, TA, Wassermann, EM, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000;48(12):11331141. doi:10.1016/S0006-3223(00)01065-9.CrossRefGoogle Scholar
Frank, E. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48(9):851. doi:10.1001/archpsyc.1991.01810330075011.CrossRefGoogle Scholar
Ballenger, JC. Current treatments of the anxiety disorders in adults. Biol Psychiatry. 1999;46(11):15791594. doi:10.1016/S0006-3223(99)00220-6.CrossRefGoogle Scholar
Alexopoulos, GS. Depression in the elderly. The Lancet. 2005;365(9475):19611970. doi:10.1016/S0140-6736(05)66665-2.CrossRefGoogle ScholarPubMed
Nierenberg, AA, Wright, EC. Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry. 1999;60(Suppl 22):711.Google Scholar
The CONSORT Group, Schulz, KF, Altman, DG, Consort, MD. 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8(1):18. doi:10.1186/1741-7015-8-18.CrossRefGoogle Scholar
Thase, ME, Rush, AJ. When at first you don’t succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry. 1997;58(Suppl 13):2329.Google Scholar
Trevizol, AP, Goldberger, KW, Mulsant, BH, et al. Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant late-life depression. Int J Geriatr Psychiatry. 2019;34(6):822827. doi:10.1002/gps.5091.CrossRefGoogle Scholar
Fava, M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003;53(8):649659. doi:10.1016/S0006-3223(03)00231-2.CrossRefGoogle Scholar
Fava, M, Davidson, KG Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am. 1996;19(2):179200. doi:10.1016/S0193-953X(05)70283-5.CrossRefGoogle Scholar